A network medicine approach to investigation and population-based validation of disease manifestations and drug repurposing for COVID-19.

A network medicine approach to investigation and population-based validation of disease manifestations and drug repurposing for COVID-19.

The global coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has led to unprecedented social and economic consequences. The risk of morbidity and mortality due to COVID-19 increases dramatically in the presence of coexisting medical...

Full description

Bibliographic Details
Main Authors: Yadi Zhou, Yuan Hou, Jiayu Shen, Reena Mehra, Asha Kallianpur, Daniel A Culver, Michaela U Gack, Samar Farha, Joe Zein, Suzy Comhair, Claudio Fiocchi, Thaddeus Stappenbeck, Timothy Chan, Charis Eng, Jae U Jung, Lara Jehi, Serpil Erzurum, Feixiong Cheng
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2020-11-01
Series:PLoS Biology
Online Access:https://doi.org/10.1371/journal.pbio.3000970

Internet

https://doi.org/10.1371/journal.pbio.3000970

Similar Items